DurvalumabDurvalumab is a human monoclonal antibody directed at human programmed death-ligand 1 (PD-L1), a negative regulator of T-cell activity. Durvalumab potentiates T-cell responses, including anti-tumour responses.
What can Sanquin do for you?
- Measure drug levels of free drug in the serum using an validated ELISA.
- Measure the immunogenicity of durvalumab.
- Provide assay reagents or co-develop novel testing strategies.
- Folllowing ISO, FDA/EMA, RUO guidelines.
Enquire about our drug level and ADA assays by emailing us at [email protected].